Saturday, July 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

Kennethcix by Kennethcix
July 4, 2026
in Analysis, Automotive & E-Mobility, DAX
0
Mercedes-Benz Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The Stuttgart automaker finds itself caught between a nascent share-price recovery and a rapidly escalating confrontation with its workforce. While the stock clawed back 4.91% last week to close at €45.40, tens of thousands of employees are walking off the job after management scrapped a scheduled bonus and demanded longer shifts without extra pay.

Around 90,000 of Mercedes-Benz’s roughly 108,000 German staff will miss out on the “transformation component” — a special tariff payment originally due in July, now pushed to next year. The company blames shrinking profits and a weak economy for the decision. On top of that, the board is pressing for extended working hours with no wage compensation, a move the works council chief Ergun Lümali described as shifting management’s own failures onto the workforce. IG Metall chairwoman Christiane Benner echoed that criticism, warning that the leadership is creating pressure instead of offering a perspective.

Technical Rebound From the Abyss

The stock’s bounce came after hitting a fresh 2024 low of €42.64 in late June. Analysts view the rally as a textbook oversold reaction. The Relative Strength Index, which had flashed extreme oversold readings, has recovered to a neutral 43.8, removing immediate technical headwinds. Historical patterns suggest such impulses can sustain a multi-week recovery, and market observers now see room to test the €50 psychological barrier.

Yet the long-term chart tells a darker tale. The shares have plunged 26.37% since the start of the year and continue to trade well below the 50-day moving average, currently at €48.44. A clean break above that line would open the path toward €50, but if the price slips back under the recent trough, the bullish signal evaporates.

Should investors sell immediately? Or is it worth buying Mercedes-Benz?

Bargain Hunters Eye Deep Value

Alongside the technical setup, fundamental metrics are drawing attention. Mercedes-Benz trades at a historically cheap valuation, with a 2026 estimated price-to-earnings ratio of just 7.7 and a 2027 multiple of 6.1 — both far below the long-term average. Long-term investors are also lured by a prospective dividend yield of 7.4%, though collecting that payout requires patience until next year. The stock’s current volatility of 29.4% will test the nerve of anyone holding on.

A Hot Summer on the Shop Floor

The labor calm is unlikely to return soon. The union is gearing up for a prolonged battle, warning of a “hot summer” that could cause costly production halts if management stays on its cost-cutting course. The next escalation is already scheduled: a large car convoy through Stuttgart on July 9, orchestrated by worker representatives.

For now, the share price is enjoying a technical reprieve, but the underlying pressure from the factory floor and the persistent downtrend leave the outlook highly uncertain. Ratchets like the 50-day average will determine whether this recovery has legs — or is just a pause before another leg lower.

Ad

Mercedes-Benz Stock: Buy or Sell?! New Mercedes-Benz Analysis from July 4 delivers the answer:

The latest Mercedes-Benz figures speak for themselves: Urgent action needed for Mercedes-Benz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 4.

Mercedes-Benz: Buy or sell? Read more here...

Tags: Mercedes-Benz
Kennethcix

Kennethcix

Related Posts

Outlook Therapeutics Stock
Analysis

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

July 4, 2026
Intuit Stock
Analysis

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

July 4, 2026
ImmunityBio Stock
Analysis

ImmunityBio’s 369% Surge Meets 13% Short Interest — A Collision Course in Biotech

July 4, 2026
Next Post
SpaceX Stock

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

Outlook Therapeutics Stock

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

FALLBACK Stock

Digital Forklift Checklists and a Growing Cyber Threat: Inside Germany’s New Electrical Safety Rules

Recommended

Xoma Stock

The Royalty Aggregator: Xoma’s Unique Path to Biotech Profits

10 months ago
The Trade Desk Stock

The Trade Desk Faces Internal Challenges Amid Agency Spending Freeze

7 months ago
Reinsurance of America Stock

Major Institutions Bet Big on Reinsurance of America Stock

10 months ago
Energy Company Markets and money

PattersonUTI Energy Shows Resilience and Growth in Fourth Quarter Earnings

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

Intuit’s Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

Lam Research’s Whiplash Week: Record High, Insider Sales, and a $600 Million China Question

Trending

Antimony Resources Stock
Commodities

Antimony Resources: A Geopolitical Bet Gets a Geological Boost

by Rodolfo Hanigan
July 4, 2026
0

The antimony market has been anything but ordinary since Beijing imposed export restrictions on the critical mineral,...

ITM Power Stock

ITM Power: Inside the 113% Volatility Stock That Just Attracted a Government Stake and a Rheinmetall Pact

July 4, 2026
FALLBACK Stock

Digital Forklift Checklists and a Growing Cyber Threat: Inside Germany’s New Electrical Safety Rules

July 4, 2026
Outlook Therapeutics Stock

Outlook Therapeutics Braces for a Five-Day Gauntlet: Shareholder Vote on Survival Followed by FDA Decision on ONS-5010

July 4, 2026
SpaceX Stock

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

July 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Antimony Resources: A Geopolitical Bet Gets a Geological Boost
  • ITM Power: Inside the 113% Volatility Stock That Just Attracted a Government Stake and a Rheinmetall Pact
  • Digital Forklift Checklists and a Growing Cyber Threat: Inside Germany’s New Electrical Safety Rules

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com